The Mindtalk app โ€” 122 free assessments, 18 journeys, 155+ guided audio sessions. Free on iOS, Android & Web.

Get the App โ†’
Assessments

Drug Addiction Test โ€” Free Substance Dependency Screening

Test whether drug use fits the pattern of substance use disorder in 3 minutes. Free in the Mindtalk app.

Important safety information

The DRUGD includes a question about thoughts of self-harm (question 9). If you have had any such thoughts recently, please reach out for support before or instead of taking this assessment โ€” you do not need to take a test to deserve help.

All lines listed are free and confidential.

Substance Use Disorder โ€” the DSM-5 criteria

SUD requires 2 or more of 11 criteria over 12 months, causing clinically significant impairment or distress:

Impaired control:

  1. Using more or longer than intended
  2. Persistent desire or unsuccessful efforts to cut down
  3. Significant time obtaining, using, or recovering
  4. Craving

Social impairment: 5. Failure to fulfill role obligations (work, home, school) 6. Continued use despite social/interpersonal problems 7. Giving up activities

Risky use: 8. Use in hazardous situations 9. Continued use despite knowing about physical/psychological problems

Pharmacological: 10. Tolerance (needing more for same effect) 11. Withdrawal

Severity:

  • 2-3 criteria = mild SUD
  • 4-5 criteria = moderate SUD
  • 6+ criteria = severe SUD

Withdrawal โ€” safety matters

Withdrawal safety varies by substance:

  • Alcohol โ€” Can be medically dangerous (seizures, delirium tremens). Supervised medical detox often essential for heavy users.
  • Benzodiazepines โ€” Can be medically dangerous (seizures). Supervised taper essential.
  • Opioids โ€” Severe but usually not medically dangerous. Very painful. MAT (buprenorphine, methadone) reduces suffering.
  • Stimulants โ€” Mainly psychological (depression, fatigue, craving).
  • Cannabis โ€” Mild (sleep disruption, irritability, appetite changes).

Never attempt cold-turkey alcohol or benzodiazepine withdrawal for heavy dependence. Medical supervision is essential.

Treatments backed by evidence

Medication-Assisted Treatment (MAT):

  • Opioid Use Disorder โ€” Buprenorphine (Suboxone), methadone, naltrexone. Gold-standard for opioid dependence. Substantially reduces overdose risk.
  • Alcohol Use Disorder โ€” Naltrexone, acamprosate, disulfiram. Effective across relapse-risk profiles.

CBT for substance use โ€” 12-16 weeks. Strong evidence. Addresses cognitions, triggers, coping.

Motivational Interviewing โ€” Especially early in treatment. Helps engage ambivalent users.

Contingency Management โ€” Reinforcement for negative drug tests. Highly effective; underused in India.

Structured inpatient / outpatient programmes โ€” Combined modalities. Cadabams has multiple options.

Twelve-step programmes (AA, NA) โ€” Help many; community support matters. Not the only path.

Common comorbidities

Substance use disorders very rarely occur in isolation:

  • Depression ~30-40% comorbid. Take PHQ-9.
  • Anxiety ~25-30% comorbid. Take GAD-7.
  • PTSD ~15-25% comorbid. Take ITQ.
  • ADHD ~15-30% comorbid. Take ASRS.
  • BPD ~50% comorbid. Take BSL-23.

Treating the comorbid condition often reduces substance use โ€” dual-diagnosis treatment is standard-of-care.

Cadabams for addiction

Cadabams has India's largest private addiction treatment infrastructure โ€” inpatient and outpatient care for:

  • Alcohol use disorder
  • Opioid use disorder (heroin, prescription opioids)
  • Stimulant use (cocaine, methamphetamine, prescription stimulants)
  • Cannabis
  • Poly-substance
  • Behavioural addictions

Contact through the Mindtalk app or Cadabams hospitals directly.

When to see a specialist

  • Substance use impairing relationships, work, health, or safety
  • Failed attempts to reduce despite wanting to
  • Withdrawal present
  • Co-occurring mental health conditions
  • Family concerns

Related reading

How to take the DRUGD

  1. 1

    Open the Drug Dependency Test in the Mindtalk app

    Tap "Take the Drug Test" to open the assessment.

  2. 2

    Answer items about substance use patterns

    For each item, describe your experience honestly. Confidential.

  3. 3

    Get your screening result

    Receive your screening result with next-step recommendations.

Frequently Asked Questions

What is Substance Use Disorder?
Substance Use Disorder (DSM-5) requires a problematic pattern of substance use causing clinically significant impairment or distress, with 2+ of 11 criteria over 12 months: (1) Using more or longer than intended; (2) Persistent desire or unsuccessful efforts to cut down; (3) Significant time obtaining, using, recovering; (4) Craving; (5) Failure to fulfill role obligations; (6) Continued use despite social/interpersonal problems; (7) Giving up activities; (8) Use in hazardous situations; (9) Continued use despite knowing about physical/psychological problems; (10) Tolerance; (11) Withdrawal. Severity: 2-3 mild, 4-5 moderate, 6+ severe.
What''s the difference between use, misuse, and disorder?
Use โ€” consuming a substance (may be occasional or recreational, no clinical impairment). Misuse โ€” using in ways not intended (higher doses, non-medical use of prescription drugs). Substance Use Disorder โ€” the clinical pattern with 2+ criteria over 12 months, causing impairment. Not everyone who uses substances has a disorder. But everyone with SUD deserves treatment access โ€” it's a medical condition, not a moral failing.
Is withdrawal dangerous?
Depends on the substance. Alcohol and benzodiazepine withdrawal can be medically dangerous (seizures, delirium tremens) โ€” supervised medical detox is often needed for heavy users. Opioid withdrawal is severe but usually not medically dangerous (though painful). Stimulant withdrawal is mainly psychological. Cannabis withdrawal is mild. NEVER attempt cold-turkey alcohol or benzodiazepine withdrawal for heavy dependence โ€” medical supervision is essential.
What treatment works?
Medication-assisted treatment (MAT) is first-line for opioid use disorder (buprenorphine, methadone, naltrexone) and effective for alcohol use disorder (naltrexone, acamprosate, disulfiram). CBT for substance use is well-evidenced. Motivational Interviewing works for engagement, particularly early in treatment. Contingency Management (reinforcement for negative drug tests) is effective. Structured programmes (Cadabams inpatient + outpatient) combine multiple modalities. Twelve-step programmes (AA, NA) help many; not the only path.
What if I''m not ready to stop?
Very common. Motivational Interviewing is designed for exactly this โ€” helping you clarify what matters to you and how substance use fits or conflicts with those values. No pressure to change; support in exploring your own ambivalence. Sometimes clarity leads to change, sometimes it leads to "I'm not ready yet." Both are OK. Cadabams and Mindtalk clinicians work with people at all readiness stages.
Is addiction a moral failing?
No. Substance Use Disorder is a medical condition with genetic, neurological, developmental, and environmental contributors. The old moralistic framing (weakness, choice, moral failing) has been replaced in mainstream medicine by the disease / medical model. Effective treatment approaches match the medical reality โ€” medication when appropriate, therapy, community support, structural change.
When should I see a specialist?
If substance use is impairing your relationships, work, health, or safety. If you've tried to reduce and can't. If withdrawal is present (physical or psychological). If mental health conditions co-occur (very common โ€” depression, anxiety, trauma, ADHD). Cadabams has India's largest private addiction treatment infrastructure. Contact through the Mindtalk app or Cadabams directly.

Need a clinician's read on your results?

A high score is a signal, not a diagnosis. Mindtalk's psychiatrists and clinical psychologists can interpret your results and recommend next steps โ€” same-day appointments available.

Ready to take the first step?

Our team of specialists is here to support your journey to better mental health.